Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Nutromics Appoints Professor Kevin W. Plaxco As Chief Scientific Officer
PRIVATESep 07, 2026•about 7 hours ago
Position
Chief Scientific Officer
Company
Nutromics
Kevin W. Plaxco
Exploration Park And MelbourneOtherBiotechnologyHealth CareMedical DeviceHealth Diagnostics
Description
Nutromics has announced the appointment of Professor Kevin W. Plaxco as Chief Scientific Officer. His expertise in DNA-based sensing technology will guide the company as it prepares for the launch of its first product in 2027.
Company Information
Company
Nutromics
Location
Victoria Street
Exploration Park And Melbourne, Victoria, AUS
About
We are an Australian MedTech company with a vision to create a world with zero preventable deaths due to the lack of timely molecular-level data.
We are developing a Continuous Molecular Monitoring platform technology that can provide clinicians with real-time and continuous data for multiple targets.
To date, we have raised $10 million, won an award for Technology Platform Solution of the Year at the National iawards, and been a Top 5 finalist in the medTech Innovator program. Our team of 15 are currently working towards our first-in-human clinical trials.
Join us on our journey to revolutionise precision medicine and put an end to preventable tragedies.
Don't miss Nutromics's next move
Get an email the moment Nutromics changes its leadership, hires an exec, or expands, usually minutes after it happens.